SPDR S&P Biotech ETF $XBI Shares Sold by Greenwich Wealth Management LLC

Greenwich Wealth Management LLC lowered its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,406 shares of the exchange traded fund’s stock after selling 1,031 shares during the quarter. Greenwich Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $780,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. DHJJ Financial Advisors Ltd. acquired a new stake in shares of SPDR S&P Biotech ETF in the 2nd quarter worth approximately $25,000. Johnson Financial Group Inc. bought a new stake in SPDR S&P Biotech ETF during the second quarter worth approximately $31,000. AlphaCore Capital LLC boosted its stake in SPDR S&P Biotech ETF by 6,650.0% during the 2nd quarter. AlphaCore Capital LLC now owns 540 shares of the exchange traded fund’s stock valued at $45,000 after purchasing an additional 532 shares in the last quarter. Quaker Wealth Management LLC boosted its stake in SPDR S&P Biotech ETF by 101.2% during the 2nd quarter. Quaker Wealth Management LLC now owns 623 shares of the exchange traded fund’s stock valued at $52,000 after purchasing an additional 53,536 shares in the last quarter. Finally, Avalon Trust Co acquired a new position in shares of SPDR S&P Biotech ETF during the 1st quarter valued at $57,000.

SPDR S&P Biotech ETF Stock Performance

XBI opened at $123.16 on Friday. The company has a market capitalization of $7.48 billion, a PE ratio of 11.47 and a beta of 0.93. The stock’s fifty day moving average is $108.95 and its 200-day moving average is $94.25. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $123.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.